SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

S51 - Cerebrovascular Disease and Interventional Neurology: Stroke Prevention and Translation

Event Time: Friday April 28, 2017 1:00 pm to 3:00 pm
Topic(s): Cerebrovascular Disease and Interventional Neurology
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Program Speakers - Tentative

Start/End Time Title Faculty
2:35 PM - 3:00 PM Discussion Nicole A. Chiota-McCollum MD 


Speaker Disclosure
Nicole A. Chiota-McCollum, MD Dr. Chiota-McCollum has nothing to disclose.

Abstract Presenters

Start Time Pub. Title Presenter
1:00 PM 001 Effectiveness and Safety of Apixaban and Rivaroxaban Versus Warfarin for the Secondary Prevention of Stroke or Systemic Embolism Among Nonvalvular Atrial Fibrillation Patients Craig Coleman
Dr. Coleman has received personal compensation for activities with Janssen Scientific affairs, LLC, Bayer Pharma AG, and BIPI . Dr. Coleman has received research support from Janssen Scientific Affairs, LLC, and Bayer Pharma AG.

1:12 PM 002 "Worth the Walk:" A Randomized Controlled Trial of a Walking Intervention to Decrease Stroke Risk Among Minority Seniors Sarah Song, MD
Dr. Song has nothing to disclose.

1:24 PM 003 Long-term Risk of Complications after Percutaneous Transcatheter Closure of Patent Foramen Ovale Alexander Merkler, MD
Dr. Merkler has nothing to disclose.

1:36 PM 004 Histopathological differences between the anterior and posterior cerebral circulation as a function of aging William Roth, MD
Dr. Roth has nothing to disclose.

1:48 PM 005 Leukocyte response in ischemic stroke is regulated by let7i microRNA Glen Jickling, MD
Dr. Jickling has nothing to disclose.

2:00 PM 006 Associations between Parkinson Disease and Stroke Benjamin Kummer, MD
Dr. Kummer has nothing to disclose.

2:12 PM 007 Recurrent Stroke after Silent Brain Infarction in Patients with Primary Brain Tumors Neal Parikh, MD
Dr. Parikh has nothing to disclose.

2:24 PM 008 Incidence of Stroke in the US Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS) Cohort David Tirschwell, MD, FAAN
Dr. Tirschwell has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Abbott.

Register Now

Related Courses

Saturday April 21, 2018

1:30 PM-3:30 PM
C22 Stroke in Young Adults and Women Aneesh Singhal MD, FAAN

Monday April 23, 2018

7:00 AM-9:00 AM
C66 Update on Medical Management of Stroke Natalia Rost MD, MPH, FAAN
1:00 PM-3:00 PM
C78 Therapeutic Temperature Modulation in the ICU Stephan Mayer MD
S15 Cerebrovascular Disease and Interventional Neurology Platform Session

Wednesday April 25, 2018

1:00 PM-3:00 PM
C151 Cerebrovascular Disease III: Update on Neuroimaging Modalities and Endovascular Therapies for Acute Ischemic Stroke Philip Gorelick MD, MPH, FAAN
3:30 PM-5:30 PM
C166 Cerebrovascular Disease IV: Telestroke Eric Anderson MD, PhD

Friday April 27, 2018

7:00 AM-9:00 AM
C217 Current Management of Incidental and Asymptomatic Cerebrovascular Lesions Seemant Chaturvedi MD, FAAN, FAHA
3:00 PM-4:00 PM
Ask Us Anything: Expert Panel on Stroke Natalia Rost MD, MPH, FAAN,
Bart Demaerschalk MD, MSc, FRCPC,
Jose Biller MD, FAAN, FACP, FAHA
3:30 PM-5:30 PM
S54 Cerebrovascular Disease and Interventional Neurology Platform Session


Forgot Password?